{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:17:03Z","timestamp":1790947023395,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.toxicon.2025.108409","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T14:59:27Z","timestamp":1747148367000},"page":"108409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Modelling long-term outcomes in patients with post-stroke spasticity with or without BoNT-A treatment on all-cause mortality and secondary cardiovascular events"],"prefix":"10.1016","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6508-5055","authenticated-orcid":false,"given":"Klemens","family":"Fheodoroff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2025.108409_bib1","series-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"key":"10.1016\/j.toxicon.2025.108409_bib2","series-title":"Unit Costs of Health and Social Care 2020","author":"Curtis","year":"2020"},{"issue":"8","key":"10.1016\/j.toxicon.2025.108409_bib3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2340\/16501977-1842","article-title":"Outcomes of ambulatory rehabilitation programmes following botulinum toxin for spasticity in adults with stroke","volume":"46","author":"Demetrios","year":"2014","journal-title":"J. Rehabil. Med."},{"key":"10.1016\/j.toxicon.2025.108409_bib4","article-title":"Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity","volume":"6","author":"Demetrios","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.toxicon.2025.108409_bib5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1212\/01.wnl.0000201253.93811.f6","article-title":"Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan Study","volume":"66","author":"Dhamoon","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.toxicon.2025.108409_bib6","first-page":"406","article-title":"Color Doppler ultrasound-guided botulinum toxin type A injection combined with an ankle foot brace for treating lower limb spasticity after a stroke","volume":"19","author":"Ding","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108409_bib7","first-page":"4","article-title":"Relationship between disability and health-related quality of life and caregiver burden in patients with upper limb poststroke spasticity","volume":"4","author":"Doan","year":"2012","journal-title":"Pharm. Manag. PM R"},{"key":"10.1016\/j.toxicon.2025.108409_bib8","doi-asserted-by":"crossref","DOI":"10.2340\/jrm.v54.2422","article-title":"Modelling long-term outcomes and risk of death for patients with post-stroke spasticity receiving Abobotulinumtoxina treatment and rehabilitation therapy","volume":"54","author":"Fheodoroff","year":"2022","journal-title":"J. Rehabil. Med."},{"issue":"10","key":"10.1016\/j.toxicon.2025.108409_bib9","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S1474-4422(15)00216-1","article-title":"Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial","volume":"14","author":"Gracies","year":"2015","journal-title":"Lancet Neurol."},{"issue":"22","key":"10.1016\/j.toxicon.2025.108409_bib10","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1212\/WNL.0000000000004687","article-title":"Efficacy and safety of abobotulinumtoxinA in spastic lower limb: randomized trial and extension","volume":"89","author":"Gracies","year":"2017","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.toxicon.2025.108409_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/mus.25721","article-title":"Effects of repeated abobotulinumtoxinA injections in upper limb spasticity","volume":"57","author":"Gracies","year":"2018","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.toxicon.2025.108409_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009535","article-title":"Quantifying the risk of heart disease following acute ischaemic stroke: a meta-analysis of over 50,000 participants","volume":"6","author":"Gunnoo","year":"2016","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.toxicon.2025.108409_bib13","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.toxicon.2025.108409_bib14","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American heart association\/American stroke association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.toxicon.2025.108409_bib15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jamda.2012.03.005","article-title":"Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study","volume":"13","author":"Lam","year":"2012","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.toxicon.2025.108409_bib16","series-title":"University of Sheffield - School of Health and Related Research - UK","first-page":"1","article-title":"NICE DSU technical support document 14: survival analysis for economic evaluations alongside clinical trials - extrapolation with patient-level data","author":"Latimer","year":"2013"},{"issue":"2","key":"10.1016\/j.toxicon.2025.108409_bib17","article-title":"AbobotulinumtoxinA and rehabilitation vs rehabilitation alone in post-stroke spasticity: a cost-utility analysis","volume":"52","author":"Lazzaro","year":"2020","journal-title":"J. Rehabil. Med."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108409_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10072-020-04797-5","article-title":"Cumulative risk of stroke recurrence over the last 10 years: a systematic review and meta-analysis","volume":"42","author":"Lin","year":"2021","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108409_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s41669-018-0086-z","article-title":"Cost effectiveness of long-term incobotulinumtoxin-A treatment in the management of post-stroke spasticity of the upper limb from the Australian payer perspective","volume":"3","author":"Makino","year":"2019","journal-title":"Pharmacoecon Open"},{"issue":"3","key":"10.1016\/j.toxicon.2025.108409_bib20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.10.002","article-title":"Malnutrition increases the incidence of death, cardiovascular events, and infections in patients with stroke after rehabilitation","volume":"27","author":"Maruyama","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"4","key":"10.1016\/j.toxicon.2025.108409_bib21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s10389-019-01161-6","article-title":"Budget impact of botulinum toxin treatment for spasticity after stroke \u2014 a German perspective","volume":"29","author":"Neusser","year":"2019","journal-title":"Journal of Public Health"},{"key":"10.1016\/j.toxicon.2025.108409_bib22","article-title":"Stroke rehabilitation: long term rehabilitation after stroke [internet]","year":"2013","journal-title":"Royal College of Physicians (UK)"},{"issue":"4","key":"10.1016\/j.toxicon.2025.108409_bib23","first-page":"381","article-title":"How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study","volume":"51","author":"Pennati","year":"2015","journal-title":"Eur. J. Phys. Rehabil. Med."},{"key":"10.1016\/j.toxicon.2025.108409_bib24","author":"Rohatgi"},{"issue":"4","key":"10.1016\/j.toxicon.2025.108409_bib25","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00702-007-0869-3","article-title":"Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity","volume":"115","author":"Rosales","year":"2008","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108409_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13561-016-0107-5","article-title":"Quality of life and costs of spasticity treatment in German stroke patients","volume":"6","author":"Rychlik","year":"2016","journal-title":"Health Econ Rev"},{"issue":"10","key":"10.1016\/j.toxicon.2025.108409_bib27","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1161\/STROKEAHA.115.010440","article-title":"Functional gain after inpatient stroke rehabilitation: correlates and impact on long-term survival","volume":"46","author":"Scrutinio","year":"2015","journal-title":"Stroke"},{"issue":"26","key":"10.1016\/j.toxicon.2025.108409_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14260","article-title":"BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A","volume":"14","author":"Shaw","year":"2010","journal-title":"Health Technol. Assess."},{"issue":"6","key":"10.1016\/j.toxicon.2025.108409_bib29","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.02.030","article-title":"Risk factors for acute heart failure and impact on in-hospital mortality after stroke","volume":"28","author":"Shima","year":"2019","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"2","key":"10.1016\/j.toxicon.2025.108409_bib30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/STROKEAHA.119.028066","article-title":"First-ever ischemic stroke and incident major adverse cardiovascular events in 93 627 older women and men","volume":"51","author":"Sposato","year":"2020","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.toxicon.2025.108409_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/toxins16020098","article-title":"Best practice guidelines for the management of patients with post-stroke spasticity: a modified scoping review","volume":"16","author":"Suputtitada","year":"2024","journal-title":"Toxins"},{"issue":"6","key":"10.1016\/j.toxicon.2025.108409_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002771","article-title":"Results from the Upper Limb International Spasticity Study-II (ULISII):a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management","volume":"3","author":"Turner-Stokes","year":"2013","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.toxicon.2025.108409_bib33","doi-asserted-by":"crossref","first-page":"jrm00157","DOI":"10.2340\/16501977-2801","article-title":"Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study","volume":"53","author":"Turner-Stokes","year":"2021","journal-title":"J. Rehabil. Med."},{"issue":"8","key":"10.1016\/j.toxicon.2025.108409_bib34","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/STROKEAHA.120.029606","article-title":"Burden of stroke in Europe: thirty-year projections of incidence, prevalence, deaths, and disability-adjusted life years","volume":"51","author":"Wafa","year":"2020","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.toxicon.2025.108409_bib35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/16501970510027312","article-title":"Cost-effectiveness of botulinum toxin type a in the treatment of post-stroke spasticity","volume":"37","author":"Ward","year":"2005","journal-title":"J. Rehabil. Med."},{"issue":"6","key":"10.1016\/j.toxicon.2025.108409_bib36","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1161\/STR.0000000000000098","article-title":"Guidelines for Adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American heart association\/American stroke association","volume":"47","author":"Winstein","year":"2016","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.toxicon.2025.108409_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001033","article-title":"Estimates of outcomes up to ten years after stroke: analysis from the prospective South London Stroke Register","volume":"8","author":"Wolfe","year":"2011","journal-title":"PLoS Med."},{"key":"10.1016\/j.toxicon.2025.108409_bib38","article-title":"Prevalence and risk factors for spasticity after stroke: a systematic review and meta-analysis","volume":"11","author":"Zeng","year":"2020","journal-title":"Front. Neurol."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010125001837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010125001837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T16:48:23Z","timestamp":1749487703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010125001837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":38,"alternative-id":["S0041010125001837"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2025.108409","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modelling long-term outcomes in patients with post-stroke spasticity with or without BoNT-A treatment on all-cause mortality and secondary cardiovascular events","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2025.108409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108409"}}